查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494582

患者参与技术市场评估：依组件、交付类型、治疗领域、功能、应用、最终用户和地区划分的机会和预测（2017-2031）

Patient Engagement Technology Market Assessment, By Component, By Delivery Type, By Therapeutic Area, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 234 Pages | 商品交期: 3-5个工作天内

价格

全球患者参与技术市场规模将从 2023 年的 204.1 亿美元增长到 2031 年的 627.8 亿美元，预计在 2024 年至 2031 年的预测期内将以 15.08% 的复合年增长率增长。

市场的成长受到有利的政府政策的出台、人口的快速增长、各种疾病的流行、行动应用程式的使用增加以及各参与者之间的战略合作伙伴关係的支持。各种医疗机构为加强 IT 基础设施而增加的投资也推动了患者参与技术的全球市场规模。这些技术提供的无缝患者帮助使医疗保健专业人员能够有效追踪患者的依从性，同时确保与患者的即时连接。

此外，领先公司增加对患者参与新创公司的投资预计将支持未来几年的市场扩张。2024 年 4 月，Providence分拆了 Praia Health。Praia Health 是一个平台，旨在透过将患者与有用的服务和资源联繫起来，帮助医疗保健提供者与患者建立更牢固的关係。A 轮融资由 Frist Cressey Ventures 完成，融资金额为 2,000 万美元，Providence Ventures, Inc.、SignalFire Management Services, LLC、Epsilon Health Investors, LLC 等参与其中。该平台旨在统一分散的点解决方案和资料来源，包括计费和护理服务、护理导航和消费者级预订。此类平台的开发将使患者旅程个人化，并为医疗保健专业人员提供对患者健康状况的准确瞭解。

慢性病的增加将推动市场需求：

全球不同地区慢性病患者数量的增加也是支持市场扩张的关键驱动因素之一。根据U.S. Centers for Disease Control and Prevention估计，截至2024年，约有3,840万人，即美国人口的11.6%，将患有糖尿病。预计各公司将投资开发以患者为中心的参与解决方案，以确保有效管理此类疾病。

该报告调查了全球患者参与技术市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构、影响市场增长的因素分析以及案例研究。简介等

目录

第1章 研究方法论

第2章 专案范围与定义

第3章 执行摘要

第4章 全球病患参与技术市场展望

  • 市场规模/预测
  • 依组件
    • 软件
    • 硬件
    • 服务
  • 依交货类型
    • 本地
    • 网路和云端的
  • 依治疗领域
    • 健康/保健
    • 慢性病管理
    • 其他
  • 依功能
    • 沟通
    • 健康追踪/分析
    • 帐单/付款
    • 程式
    • 病患教育
    • 其他
  • 依用途
    • PHM (Population Health Management)
    • 住院病人健康管理
    • 门诊健康管理
    • 其他
  • 依最终用户
    • 医疗服务提供方
    • 保险公司
    • 病人
    • 其他
  • 依地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 依公司划分的市场占有率

第五章全球病患参与技术市场展望：依地区

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章 市场测绘，2023 年

  • 依组件
  • 依交货类型
  • 依治疗领域
  • 依功能
  • 依用途
  • 依最终用户
  • 依地区

第7章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

  • 成长动力
  • 生长抑制因素（问题/限制）

第9章 监理架构与创新

  • 专利情况
  • 监管审批
  • 创新/新兴技术

第十章 主要公司情况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名市场领导者的市场收入分析
  • 併购/合资（如适用）
  • SWOT分析（5家参与企业）
  • 专利分析（如果适用）

第11章 价格分析

第12章 案例研究

第13章 主要公司展望

  • Oracle Corporation
  • IQVIA Holdings Inc.
  • Koninklijke Philips N.V.
  • Klara Technologies, Inc.
  • Oneview Healthcare PLC
  • Epic Systems Corporation
  • Lincor Inc.
  • Orion Health Ltd.
  • MEDHOST Inc.
  • Nuance Communications, Inc.

第14章 战略建议

第15章 关于我们公司/免责声明

Product Code: MX11457

Global patient engagement technology market is projected to witness a CAGR of 15.08% during the forecast period 2024-2031F, growing from USD 20.41 billion in 2023 to USD 62.78 billion in 2031F. The market's growth is supported by the introduction of favorable government policies, rapid population growth, the increasing prevalence of various diseases, the rising usage of mobile applications, and strategic partnerships between various market players. The rising investments towards enhancing IT infrastructure by various healthcare establishments are bolstering the global patient engagement technology market size. The seamless patient assistance offered by these technologies allows healthcare professionals to track patient adherence effectively while ensuring a real-time connection with the patients.

Additionally, the increasing investments by leading companies towards patient engagement startups are expected to support the expansion of the market in the coming years. In April 2024, Providence spun out Praia Health, a platform designed to aid healthcare providers in building strong relationships with their patients by connecting them to helpful services and resources. The Series A funding round was closed at USD 20 million by Frist Cressey Ventures and includes participants such as Providence Ventures, Inc., SignalFire Management Services, L.L.C., and Epsilon Health Investors, LLC. The platform aims to unify fragmented point solutions and data sources, including those designed for billing and care delivery, care navigation, and booking appointments at the consumer level. With the development of such platforms, personalization of the patients' healthcare journeys will become possible, and the healthcare professionals will be provided with an accurate picture of the patient's health.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rise in the number of patients living with various chronic diseases in various regions across the globe is one of the major drivers supporting the expansion of the market. According to the estimates of the U.S. Centers for Disease Control and Prevention, approximately 38.4 million individuals (accounting for 11.6% of the population of the United States) are living with diabetes as of 2024. Thus, various companies should be encouraged to invest in the development of patient-centric engagement solutions to ensure the effective management of such diseases.

Patient engagement technologies increase the patient's information accessibility and improve healthcare outcomes. They are also responsible for reducing expenses by streamlining workflow and improving patient coordination. In November 2023, Prisma Health, the largest healthcare provider in South Carolina, announced that they saved USD 4 million within the first two years by incorporating digital patient communication. The healthcare provider made these savings with the help of Artera, the patient engagement company. Meanwhile, to enhance the quality of care provided to the patients, the emphasis on developing novel technologies and launching advanced products is also increasing, resulting in the introduction of novel patient engagement solutions.

Rising Mergers, Collaborations and Acquisitions Support Market Growth

The increasing investments by various companies in developing novel products and software are expected to provide lucrative growth opportunities for the market in the coming years. Such activities support the development of novel products and technologies and allow companies to expand their customer base, increasing patient accessibility to various technologies. In January 2024, Innovaccer Inc., the leading digital healthcare company, announced the acquisition of Cured Inc., a CRM and healthcare digital marketing platform. The deal allowed the digital healthcare company to add 20 new customers to its portfolio of approximately 95 digital health and health system clients. Some of Cured's customers include HonorHealth, VCU Health, Sutter Health, and UCHealth. The accusation is expected to aid Innovaccer in becoming a leader in patient experience technology and execute its forward strategy.

North America Accounts for a Significant Share of the Market

The growth of the market in the region can be attributed to the increasing emphasis on enhancing the quality of care provided to patients, the rapid expansion of the healthcare sector, the strong presence of leading market players, and the rising acceptance of advanced technologies and services. Patient engagement technology allows healthcare professionals to gather actionable patient health data, reducing costs for healthcare providers and patients and enhancing the patient experience, thus bolstering their utilization. The growing efforts of the various companies based in the region towards developing advanced solutions are also supporting the market expansion. For instance, in September 2023, Zocdoc, Inc., one of the leading appointment booking platforms, launched its free suite of tools to aid healthcare providers in managing, keeping, and reaching patients. The company is expected to continue its efforts to support the enhancement of the tools, provide patient-provider messaging, and incorporate additional services such as facilitation of payments, among others, to bolster patient engagement and save time on different admin tasks. Such developments are also expected to support the growth of the region's market in the coming years.

Software Account for Significant Global Patient Engagement Technology Market Share

The software segment will account for a significant market share in the coming years. This growth can be attributed to various healthcare institutions' rising adoption of software to streamline workflow and provide enhanced patient experience. Furthermore, such software also aids in improving the quality of care provided for various chronic diseases and disorders, including cancer. According to the estimates of the National Cancer Institute, in 2022, 20 million new cases of cancer were reported, and the number is expected to increase to 29.9 million by 2040. This increase in cancer cases is propelling the requirement for patient engagement software to enhance oncology care as the software ensures focused patient interaction while providing intelligent symptom management and enabling digital patient monitoring.

Future Market Scenario (2024-2031F)

According to the global patient engagement technology market analysis, the market is expected to receive lucrative growth opportunities in the coming years. Patient engagement tools are expected to be used in research studies as an intervention or treatment for various diseases and disorders. For instance, Stanford University is conducting an interventional study that is expected to conclude in August 2025 to improve access and adherence to overactive bladder treatment with the help of mobile technology-based interventions and personalized behavioral modifications. The study aims to evaluate the effectiveness of a patient-centered tool in initiating the treatment.

Technological innovations in patient engagement are expected to deliver digital healthcare transformation in the coming years. Omnichannel healthcare is expected to become an integral component of healthcare digitalization, aiding patients in receiving a unified pathway to enhance their experience. The digital transformation of the healthcare sector with the help of artificial intelligence is expected to drive the market's growth. Artificial intelligence will allow the completion of various repetitive operations and tasks time-efficiently, enhancing patient experience and ensuring a deeper engagement among patients and their doctors.

Key Players Landscape and Outlook

The increasing partnerships between various market players support the market's growth to elevate the quality of care provided to patients. In April 2024, Linkwell Health, a healthcare-based consumer engagement technology company and Matrix Medical Network, one of the leading providers of in-home health assessments, announced a partnership to boost engagement with Matrix's services and enhance the patient experience. Matrix will be supported by Linkwell with omni-channel engagement journeys to encourage health plan members to take charge of their health. Linkwell's leading patient activation and engagement capabilities are expected to aid the organization in focusing on their core expertise.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Patient Engagement Technology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Component
    • 4.2.1. Software
      • 4.2.1.1. Integrated Software
      • 4.2.1.2. Standalone Software
    • 4.2.2. Hardware
      • 4.2.2.1. Tablets
      • 4.2.2.2. In-room Television
      • 4.2.2.3. Integrated Bedside Terminals/Assisted Devices
    • 4.2.3. Services
      • 4.2.3.1. Consulting
      • 4.2.3.2. Support and Maintenance
      • 4.2.3.3. Training and Implementation
      • 4.2.3.4. Others
  • 4.3. By Delivery Type
    • 4.3.1. On Premise
    • 4.3.2. Web and Cloud-based
  • 4.4. By Therapeutic Area
    • 4.4.1. Health and Wellness
    • 4.4.2. Chronic Disease Management
    • 4.4.3. Others
  • 4.5. By Functionality
    • 4.5.1. Communication
    • 4.5.2. Health Tracking and Insights
    • 4.5.3. Billing and Payments
    • 4.5.4. Administrative
    • 4.5.5. Patient Education
    • 4.5.6. Others
  • 4.6. By Application
    • 4.6.1. Population Health Management
    • 4.6.2. In-patient Health Management
    • 4.6.3. Outpatient Health Management
    • 4.6.4. Others
  • 4.7. By End-user
    • 4.7.1. Healthcare Providers
      • 4.7.1.1. Ambulatory Care Centers
      • 4.7.1.2. Home Healthcare Providers
      • 4.7.1.3. Hospitals
    • 4.7.2. Payers
      • 4.7.2.1. Public
      • 4.7.2.2. Private
    • 4.7.3. Patients
    • 4.7.4. Others
  • 4.8. By Region
    • 4.8.1. North America
    • 4.8.2. South America
    • 4.8.3. Europe
    • 4.8.4. Asia-Pacific
    • 4.8.5. Middle East and Africa
  • 4.9. By Company Market Share (%), 2023

5. Global Patient Engagement Technology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Component
      • 5.1.2.1. Software
        • 5.1.2.1.1. Integrated Software
        • 5.1.2.1.2. Standalone Software
      • 5.1.2.2. Hardware
        • 5.1.2.2.1. Tablets
        • 5.1.2.2.2. In-room Television
        • 5.1.2.2.3. Integrated Bedside Terminals/Assisted Devices
      • 5.1.2.3. Services
        • 5.1.2.3.1. Consulting
        • 5.1.2.3.2. Support and Maintenance
        • 5.1.2.3.3. Training and Implementation
        • 5.1.2.3.4. Others
    • 5.1.3. By Delivery Type
      • 5.1.3.1. On Premise
      • 5.1.3.2. Web and Cloud-based
    • 5.1.4. By Therapeutic Area
      • 5.1.4.1. Health and Wellness
      • 5.1.4.2. Chronic Disease Management
      • 5.1.4.3. Others
    • 5.1.5. By Functionality
      • 5.1.5.1. Communication
      • 5.1.5.2. Health Tracking and Insights
      • 5.1.5.3. Billing and Payments
      • 5.1.5.4. Administrative
      • 5.1.5.5. Patient Education
      • 5.1.5.6. Others
    • 5.1.6. By Application
      • 5.1.6.1. Population Health Management
      • 5.1.6.2. In-patient Health Management
      • 5.1.6.3. Outpatient Health Management
      • 5.1.6.4. Others
    • 5.1.7. By End-user
      • 5.1.7.1. Healthcare Providers
        • 5.1.7.1.1. Ambulatory Care Centers
        • 5.1.7.1.2. Home Healthcare Providers
        • 5.1.7.1.3. Hospitals
      • 5.1.7.2. Payers
        • 5.1.7.2.1. Public
        • 5.1.7.2.2. Private
      • 5.1.7.3. Patients
      • 5.1.7.4. Others
    • 5.1.8. United States*
      • 5.1.8.1. Market Size & Forecast
        • 5.1.8.1.1. By Value
      • 5.1.8.2. By Component
        • 5.1.8.2.1. Software
          • 5.1.8.2.1.1. Integrated Software
          • 5.1.8.2.1.2. Standalone Software
        • 5.1.8.2.2. Hardware
          • 5.1.8.2.2.1. Tablets
          • 5.1.8.2.2.2. In-Room Television
          • 5.1.8.2.2.3. Integrated Bedside Terminals/Assisted Devices
        • 5.1.8.2.3. Services
          • 5.1.8.2.3.1. Consulting
          • 5.1.8.2.3.2. Support and Maintenance
          • 5.1.8.2.3.3. Training and Implementation
          • 5.1.8.2.3.4. Others
      • 5.1.8.3. By Delivery Type
        • 5.1.8.3.1. On Premise
        • 5.1.8.3.2. Web and Cloud-based
      • 5.1.8.4. By Therapeutic Area
        • 5.1.8.4.1. Health and Wellness
        • 5.1.8.4.2. Chronic Disease Management
        • 5.1.8.4.3. Others
      • 5.1.8.5. By Functionality
        • 5.1.8.5.1. Communication
        • 5.1.8.5.2. Health Tracking and Insights
        • 5.1.8.5.3. Billing and Payments
        • 5.1.8.5.4. Administrative
        • 5.1.8.5.5. Patient Education
        • 5.1.8.5.6. Others
      • 5.1.8.6. By Application
        • 5.1.8.6.1. Population Health Management
        • 5.1.8.6.2. In-patient Health Management
        • 5.1.8.6.3. Outpatient Health Management
        • 5.1.8.6.4. Others
      • 5.1.8.7. By End-user
        • 5.1.8.7.1. Healthcare Providers
          • 5.1.8.7.1.1. Ambulatory Care Centers
          • 5.1.8.7.1.2. Home Healthcare Providers
          • 5.1.8.7.1.3. Hospitals
        • 5.1.8.7.2. Payers
          • 5.1.8.7.2.1. Public
          • 5.1.8.7.2.2. Private
        • 5.1.8.7.3. Patients
        • 5.1.8.7.4. Others
    • 5.1.9. Canada
    • 5.1.10. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Component
  • 6.2. By Delivery Type
  • 6.3. By Therapeutic Area
  • 6.4. By Functionality
  • 6.5. By Application
  • 6.6. By End-user
  • 6.7. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Oracle Corporation
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. IQVIA Holdings Inc.
  • 13.3. Koninklijke Philips N.V.
  • 13.4. Klara Technologies, Inc.
  • 13.5. Oneview Healthcare PLC
  • 13.6. Epic Systems Corporation
  • 13.7. Lincor Inc.
  • 13.8. Orion Health Ltd.
  • 13.9. MEDHOST Inc.
  • 13.10. Nuance Communications, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 3. Global Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 4. Global Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 5. Global Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 6. Global Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Patient Engagement Technology Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 11. North America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 12. North America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 13. North America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 14. North America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 19. United States Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 20. United States Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 21. United States Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 22. United States Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 26. Canada Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 27. Canada Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 28. Canada Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 29. Canada Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 33. Mexico Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 34. Mexico Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 35. Mexico Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 36. Mexico Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 40. Europe Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 41. Europe Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 42. Europe Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 43. Europe Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 48. Germany Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 49. Germany Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 50. Germany Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 51. Germany Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 55. France Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 56. France Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 57. France Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 58. France Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 59. France Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 62. Italy Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 63. Italy Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 64. Italy Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 65. Italy Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 69. United Kingdom Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 70. United Kingdom Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 71. United Kingdom Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 72. United Kingdom Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 76. Russia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 77. Russia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 78. Russia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 79. Russia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 80.
  • Figure 81. Russia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 82. Netherlands Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Netherlands Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 84. Netherlands Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 85. Netherlands Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 86. Netherlands Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 87. Netherlands Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 88. Netherlands Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 89. Spain Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 90. Spain Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 91. Spain Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 92. Spain Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 93. Spain Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 94. Spain Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 95. Spain Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 96. Turkey Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 97. Turkey Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 98. Turkey Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 99. Turkey Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 100. Turkey Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 101. Turkey Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 102. Turkey Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 103. Poland Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 104. Poland Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 105. Poland Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 106. Poland Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 107. Poland Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 108. Poland Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 109. Poland Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 110. South America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. South America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 112. South America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 113. South America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 114. South America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 115. South America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 116. South America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 117. South America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 118. Brazil Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 119. Brazil Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 120. Brazil Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 121. Brazil Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 122. Brazil Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 123. Brazil Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 124. Brazil Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 125. Argentina Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 126. Argentina Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 127. Argentina Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 128. Argentina Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 129. Argentina Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 130. Argentina Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 131. Argentina Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 132. Asia-Pacific Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Asia-Pacific Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 134. Asia-Pacific Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 135. Asia-Pacific Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 136. Asia-Pacific Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 137. Asia-Pacific Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 138. Asia-Pacific Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 139. Asia-Pacific Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 140. India Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 141. India Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 142. India Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 143. India Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 144. India Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 145. India Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 146. India Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 147. China Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. China Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 149. China Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 150. China Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 151. China Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 152. China Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 153. China Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 154. Japan Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 155. Japan Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 156. Japan Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 157. Japan Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 158. Japan Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 159. Japan Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 160. Japan Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 161. Australia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 162. Australia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 163. Australia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 164. Australia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 165. Australia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 166. Australia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 167. Australia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 168. Vietnam Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Vietnam Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 170. Vietnam Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 171. Vietnam Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 172. Vietnam Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 173. Vietnam Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 174. Vietnam Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 175. South Korea Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. South Korea Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 177. South Korea Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 178. South Korea Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 179. South Korea Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 180. South Korea Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 181. South Korea Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 182. Indonesia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 183. Indonesia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 184. Indonesia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 185. Indonesia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 186. Indonesia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 187. Indonesia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 188. Indonesia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 189. Philippines Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 190. Philippines Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 191. Philippines Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 192. Philippines Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 193. Philippines Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 194. Philippines Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 195. Philippines Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 196. Middle East & Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 197. Middle East & Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 198. Middle East & Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 199. Middle East & Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 200. Middle East & Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 201. Middle East & Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 202. Middle East & Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 203. Middle East & Africa Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 204. Saudi Arabia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 205. Saudi Arabia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 206. Saudi Arabia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 207. Saudi Arabia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 208. Saudi Arabia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 209. Saudi Arabia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 210. Saudi Arabia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 211. UAE Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 212. UAE Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 213. UAE Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 214. UAE Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 215. UAE Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 216. UAE Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 217. UAE Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 218. South Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 219. South Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 220. South Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 221. South Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 222. South Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 223. South Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 224. South Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 225. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Delivery Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Therapeutic Area Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 230. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 231. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023